What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Cancer
Marina B. Klein mostly deals with Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort study and Cohort.
Her biological study spans a wide range of topics, including Coinfection, Surgery and Hepatitis C virus.
Her research in Coinfection intersects with topics in Gastroenterology, Hepatitis C and Retrospective cohort study.
The study incorporates disciplines such as Logistic regression, Increased risk and Etiology in addition to Immunology.
Her work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Absolute risk reduction, Young adult, Gerontology, Case-control study and Public health.
Marina B. Klein interconnects Prospective cohort study and Incidence in the investigation of issues within Cohort study.
Her most cited work include:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Effect of early versus deferred antiretroviral therapy for HIV on survival. (970 citations)
- Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. (806 citations)
What are the main themes of her work throughout her whole career to date?
Marina B. Klein spends much of her time researching Internal medicine, Cohort, Immunology, Hepatitis C and Hepatitis C virus.
The various areas that she examines in her Internal medicine study include Coinfection, Gastroenterology and Viral load.
Her Cohort research includes themes of Cohort study, Regimen, Acquired immunodeficiency syndrome, Confidence interval and Proportional hazards model.
Her Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Young adult and Gerontology.
As part of her studies on Immunology, she often connects relevant subjects like Oncology.
She studied Hepatitis C and Hepatitis B that intersect with Viral hepatitis.
She most often published in these fields:
- Internal medicine (57.89%)
- Cohort (40.87%)
- Immunology (34.98%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (57.89%)
- Cohort (40.87%)
- Hepatitis C (30.96%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Cohort, Hepatitis C, Hepatitis C virus and Viral load.
Her Internal medicine research includes elements of Gastroenterology and Coinfection.
The concepts of her Cohort study are interwoven with issues in Proxy, Hepatitis B, Item response theory and Acquired immunodeficiency syndrome.
Her Hepatitis C study integrates concerns from other disciplines, such as Direct acting, Quality of life, Incidence and Poisson regression.
Her DIRECT ACTING ANTIVIRALS, Hcv treatment and Hcv elimination study in the realm of Hepatitis C virus interacts with subjects such as Prison.
Her Viral load study is related to the wider topic of Immunology.
Between 2017 and 2021, her most popular works were:
- Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission (111 citations)
- Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial. (56 citations)
- The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. (47 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Cancer
Marina B. Klein mainly focuses on Internal medicine, Cohort, Hepatitis C, Hepatitis C virus and Viral load.
Her work in Internal medicine is not limited to one particular discipline; it also encompasses Gastroenterology.
Her work deals with themes such as Hazard ratio, Acquired immunodeficiency syndrome, Proportional hazards model, Retention in care and Care Continuum, which intersect with Cohort.
Her study in Hepatitis C is interdisciplinary in nature, drawing from both Discontinuation, Incidence, Hepacivirus, Infectious disease and Pediatrics.
The Hepatitis C virus study combines topics in areas such as Coinfection and Early results.
Her Viral load study results in a more complete grasp of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
